domingo, 12 de julio de 2026

Experimental drug shields nerve cells from damage caused by ALS +++++++

Experimental drug shields nerve cells from damage caused by ALS https://www.news-medical.net/news/20260703/Experimental-drug-shields-nerve-cells-from-damage-caused-by-ALS.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_7_july_2026 Experimental drug shields nerve cells from damage caused by ALSAmyotrophic Lateral Sclerosis, or ALS, received widespread awareness in the summer of 2014 thanks to an Ice Bucket Challenge. Millions of people participated in the challenge, drenching themselves in ice cold water to bring visibility to this devastating neurodegenerative disease and generate charitable donations for research. LMU researchers discover new genetic cause of Crohn's disease https://www.news-medical.net/news/20260624/LMU-researchers-discover-new-genetic-cause-of-Crohns-disease.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_7_july_2026 LMU researchers discover new genetic cause of Crohn's diseaseA team led by LMU physician Daniel Kotlarz has identified a previously unknown genetic cause of Crohn's disease. UC San Diego study reveals genetic causes of rare neuromuscular disorders https://www.news-medical.net/news/20260701/UC-San-Diego-study-reveals-genetic-causes-of-rare-neuromuscular-disorders.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_7_july_2026 UC San Diego study reveals genetic causes of rare neuromuscular disordersScientists at the University of California San Diego have uncovered how genetic mutations cause a rare group of inherited neuromuscular disorders and identified promising new strategies to correct them, including a potential new use for an existing antidepressant. Scientists uncover immune mechanisms driving rare gastrointestinal disorder https://www.news-medical.net/news/20260626/Scientists-uncover-immune-mechanisms-driving-rare-gastrointestinal-disorder.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_7_july_2026 Scientists uncover immune mechanisms driving rare gastrointestinal disorderA collaborative team led by Dr. Jingnan Li and Dr. Ji Li at Peking Union Medical College Hospital, together with Associate Professor Xiaohuan Guo at Tsinghua University and Academician Ye-Guang Chen at Tsinghua University School of Life Sciences, published a study in Volume 2, article number 28 of the journal Immunity & Inflammation on June 17, 2026. AI image-based risk scores enable dynamic breast cancer assessment https://www.news-medical.net/news/20260623/AI-image-based-risk-scores-enable-dynamic-breast-cancer-assessment.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_7_july_2026 AI image-based risk scores enable dynamic breast cancer assessmentUsing artificial intelligence (AI), researchers found that image-based risk scores for breast cancer derived from screening mammograms evolve over time and differ between women who develop cancer and those who do not, opening the door to a new era of dynamic breast cancer risk assessment. Study potential new therapeutic strategy for patients with ATRX-mutant gliomas https://www.news-medical.net/news/20260701/Study-potential-new-therapeutic-strategy-for-patients-with-ATRX-mutant-gliomas.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_7_july_2026 Study potential new therapeutic strategy for patients with ATRX-mutant gliomasA new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common genetic alterations in glioma rewires the cancer cell genome to fuel tumor progression, suggesting a potential new therapeutic strategy for patients with ATRX-mutant gliomas. New diagnostic tool bypasses blood-brain barrier to detect autism early https://www.news-medical.net/news/20260630/New-diagnostic-tool-bypasses-blood-brain-barrier-to-detect-autism-early.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_7_july_2026 New diagnostic tool bypasses blood-brain barrier to detect autism earlyA study published in NeuroMarkers showed that a nanosensor can measure nitric oxide (NO) from patient-derived stem cells to distinguish autism spectrum disorder (ASD) from intellectual disability (ID), even when both conditions share the exact same genetic mutation.

No hay comentarios:

Publicar un comentario